Precision For Medicine’s Post

Oncology Practice Management and Practice Management Institute are proud to present our exclusive series on optimizing the patient experience! In this month’s issue: How to Communicate With an Angry Patient as an Oncology Healthcare Professional: Improving the patient experience through empathy, active listening, and de-escalation techniques https://lnkd.in/grbGuce2 In next month’s edition, we will present strategies to address scheduling challenges. Don’t miss this series, which includes some really great information that can be of immense benefit to your patients AND your team, regardless of specialty! This article was reviewed by PMI faculty member Jan Hailey, MHL, CMC, CMCO, CMIS, CMOM, CMCA-E/M.

This would be a great opportunity to get a jump on your Clinical Trial planning. If your planning or even just thinking about a trial in 2025, it is not too early to talk to potential Clinical Trial CRO partners. All we do at Translational Drug Development (TD2) is Oncology. Parris is your goto to learn about the TD2 difference. Curious what that is? Stop by and talk with Parris! #oncology #clinicaltrial #cro #clinicalcro #oncologytrial #oncologycro #cancertherapeuticdevelopment

In this new video, Chris Barnes, Executive Director of Alabama Oncology, shares how Cardinal Health collaborates with his practice by bringing innovative technology and support to help the practice pursue its strategic priorities and provide the best possible patient care. Watch the video: https://lnkd.in/g2HFFWyg .

In this new video, Chris Barnes, Executive Director of Alabama Oncology, shares how Cardinal Health collaborates with his practice by bringing innovative technology and support to help the practice pursue its strategic priorities and provide the best possible patient care. Watch the video: https://lnkd.in/g2HFFWyg .

Considering and quantifying the cost opportunity for oncology clinical trial participants and their primary caregiver is important for many reasons. ✨Please share your related experiences. ✨Together, we can learn, grow and improve oncology clinical trial short and long term patient-centricity. ✨#PatientCentricOncologyTrials #PatientCentricity #PatientCentricityMatters #GrowTogether

Explore SDC Insights' top-tier Patient Profiles for CNS and Oncology studies. Our process ensures timely, budget-friendly deliveries and provides real-time updates on adverse events and protocol deviations, empowering swift decision-making. Discover why clients trust us for targeted, efficient data insights. https://bit.ly/4cUXfcB #PatientProfiles #ClinicalResearch #SDCInsights #OncologyResearch #CNSResearch #HealthcareInnovation

At Oncology Convergence, we specialize in navigating the complexities of 340B hospital billing, making sure that hospitals can fully benefit from the program's offerings. Whether it's medical oncology billing, radiation oncology billing, or any part of the 340B billing procedure, we're here to streamline your processes and ensure timely, accurate claims submissions. Don’t miss out on maximizing your revenue and taking your hospital's financial fitness to the next level. Oncology Convergence: Where Treatment and Profitability Meet Learn more: #340BHospitalBilling #MedicalBilling https://lnkd.in/e4FTvPQ6 

How do oncology providers build lasting relationships and deep trust with their patients? In a thought-provoking panel discussion, oncology experts emphasized the critical need for improved patient engagement strategies, especially in communities with historical barriers to trust. Read the session summary to learn about actionable tools and strategies for fostering patient trust and engagement: https://lnkd.in/gVM7T2kC

🌟 Clinical Tips from Primo 2024: World-renowned experts from top medical institutions are sharing the latest and most relevant information presented at the PRIMO meeting. From Payor Benefits Design Changing Oncology Care Delivery to New Approaches and Advances in the Therapy of Gliomas, this year’s insights are invaluable. Stay tuned for Primo 2025! 🙌🏼💡👩⚕📚

In this edition of the New Medicines, Novel Insights newsletter, Parexel’s Jakki James and Kristina Reeder review the frustratingly limited patient access in precision oncology, the root causes, and five best practices that can bridge the gap. Learn how oncology experts are empowering patients, sites, and physicians to participate in and accelerate precision oncology. Read the full article below and subscribe to stay up to date on the latest #NovelInsights from our clinical trial newsletter! #PatientsFirst #WithHeart #PrecisionOncology #Oncology